These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9593116)

  • 41. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
    Hughes WT
    Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imbalance between Pneumocystis carinii cysts and trophozoites in bronchoalveolar lavage fluid from patients with pneumocystosis receiving prophylaxis.
    Tamburrini E; Mencarini P; Visconti E; De Luca A; Zolfo M; Siracusano A; Ortona E; Murri R; Antinori A
    J Med Microbiol; 1996 Aug; 45(2):146-8. PubMed ID: 8683551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atovaquone as prophylaxis against Pneumocystis carinii pneumonia.
    Fisher MJ; Gazzard BG; Hawkins DA; Nelson MR
    J Infect; 1994 Jan; 28(1):103-4. PubMed ID: 8163822
    [No Abstract]   [Full Text] [Related]  

  • 44. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M; Hirschel B; Lazzarin A; Heald A; Pechère M; Rüttimann S; Iten A; von Overbeck J; Oertle D; Praz G
    Clin Infect Dis; 1995 Mar; 20(3):531-41. PubMed ID: 7756472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pneumocystis carinii pneumonia].
    Szabados A; Schierz G; Deinhardt F
    Internist (Berl); 1985 Jun; 26(6):335-40. PubMed ID: 3897099
    [No Abstract]   [Full Text] [Related]  

  • 46. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia.
    Kovacs JA; Gill VJ; Meshnick S; Masur H
    JAMA; 2001 Nov; 286(19):2450-60. PubMed ID: 11712941
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.
    Evernden C; Dowhan M; Dabas R; Chaudhry A; Kalra A; Dharmani-Khan P; Gregson D; Johnson A; Jupp J; Jimenez-Zepeda V; Jamani K; Duggan P; Tay J; Khan F; Daly A; Storek J
    Cytotherapy; 2020 Jan; 22(1):27-34. PubMed ID: 31889628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylaxis and treatment of Pneumocystis carinii pneumonia.
    O'Doherty MJ; Bateman NT
    Br J Hosp Med; 1991 May; 45(5):277-8, 280, 283. PubMed ID: 1676607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current issues in the treatment and prophylaxis of Pneumocystis carinii pneumonia in HIV infection.
    Morris-Jones SD; Easterbrook PJ
    J Antimicrob Chemother; 1997 Sep; 40(3):315-8. PubMed ID: 9338481
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
    Connelly RT; Lourwood DL
    Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review.
    Hughes WT
    Clin Infect Dis; 1998 Jul; 27(1):191-204. PubMed ID: 9675476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention and treatment of Pneumocystis carinii pneumonia in patients infected with HIV.
    Drug Ther Bull; 1994 Feb; 32(2):12-5. PubMed ID: 7654282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.
    Freedberg KA; Tosteson AN; Cohen CJ; Cotton DJ
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):521-31. PubMed ID: 1673157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group.
    Dohn MN; Weinberg WG; Torres RA; Follansbee SE; Caldwell PT; Scott JD; Gathe JC; Haghighat DP; Sampson JH; Spotkov J; Deresinski SC; Meyer RD; Lancaster DJ
    Ann Intern Med; 1994 Aug; 121(3):174-80. PubMed ID: 7880228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Atovaquone as prophylaxis for Pneumocystis carinii.
    Vilar FJ; McKendrick MW; Nash C
    Int J STD AIDS; 1996 Jul; 7(4):302. PubMed ID: 8876368
    [No Abstract]   [Full Text] [Related]  

  • 58. Atovaquone for Pneumocystis carinii pneumonia.
    Med Lett Drugs Ther; 1993 Apr; 35(893):28-9. PubMed ID: 8450807
    [No Abstract]   [Full Text] [Related]  

  • 59. Preventing opportunistic infections.
    Cheng B
    PI Perspect; 1995 May; (no 16):14-5. PubMed ID: 11362422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Breakthrough Pneumocystis carinii infections in lung and heart-lung transplant patients with chemoprophylaxis.
    Halme M; Lautenschlager I; Mattila S; Tukiainen P
    Transplant Proc; 1999; 31(1-2):197. PubMed ID: 10083076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.